Ocuphire Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Revenue	19.05	39.85	0.59	0	0	0	0	0	0	0	Upgrade
Revenue Growth (YoY)	-52.20%	6665.70%	-	-	-	-	-	-	-	-	Upgrade
Gross Profit	19.05	39.85	0.59	0	0	0	0	0	0	0	Upgrade
Selling, General & Admin	11.96	7.27	8.12	2.82	1.82	7.43	6.64	6.32	6.12	6.25	Upgrade
Research & Development	17.65	14.36	15.17	6.65	2.37	13.11	10.72	10.09	12.15	7.02	Upgrade
Other Operating Expenses	0	0	0	10.5	0	0	0	0	0	0	Upgrade
Operating Expenses	29.61	21.62	23.29	19.97	4.19	20.54	17.35	16.41	18.26	13.27	Upgrade
Operating Income	-10.56	18.23	-22.71	-19.97	-4.19	-20.54	-17.35	-16.41	-18.26	-13.27	Upgrade
Interest Expense / Income	0	0.01	0	6.85	1.41	0	0.55	0.31	0.21	0.21	Upgrade
Other Expense / Income	-0.59	0.01	33.99	-2.2	0.57	-6.17	7.39	-7.42	-4.09	5.05	Upgrade
Pretax Income	-9.97	18.2	-56.69	-24.62	-6.17	-14.37	-25.29	-9.31	-14.38	-18.52	Upgrade
Income Tax	0.01	0.32	0	0	0	0	0	0	0	0	Upgrade
Net Income	-9.99	17.89	-56.69	-24.62	-6.17	-14.37	-25.29	-9.31	-14.38	-18.52	Upgrade
Shares Outstanding (Basic)	22	20	15	5	3	1	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	22	21	15	5	3	1	1	0	0	0	Upgrade
Shares Change	4.82%	38.68%	218.65%	63.84%	315.53%	19.98%	25.96%	19.22%	3.57%	36.89%	Upgrade
EPS (Basic)	-0.46	0.90	-3.82	-5.28	-2.17	-21.00	-44.16	-20.64	-37.92	-52.80	Upgrade
EPS (Diluted)	-0.46	0.87	-3.82	-5.28	-2.17	-21.00	-44.16	-20.64	-37.92	-52.80	Upgrade
Free Cash Flow	-1.11	14.31	-19.37	-6.8	-3.62	-18.88	-15.5	-13.24	-17.41	-11.08	Upgrade
Free Cash Flow Per Share	-0.05	0.72	-1.30	-1.46	-1.27	-27.57	-27.15	-29.22	-45.83	-30.21	Upgrade
Gross Margin	100.00%	100.00%	100.00%	-	-	-	-	-	-	-	Upgrade
Operating Margin	-55.45%	45.74%	-3854.84%	-	-	-	-	-	-	-	Upgrade
Profit Margin	-52.42%	44.89%	-9625.30%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-5.84%	35.92%	-3288.62%	-	-	-	-	-	-	-	Upgrade
Effective Tax Rate	-	1.73%	-	-	-	-	-	-	-	-	Upgrade
EBITDA	-9.97	18.22	-56.69	-17.77	-4.76	-14.32	-24.7	-8.96	-14.15	-18.29	Upgrade
EBITDA Margin	-52.33%	45.71%	-9624.28%	-	-	-	-	-	-	-	Upgrade
Depreciation & Amortization	0.01	0	0	0.01	0	0.05	0.04	0.03	0.03	0.03	Upgrade
EBIT	-9.97	18.21	-56.69	-17.77	-4.76	-14.37	-24.74	-8.99	-14.17	-18.32	Upgrade
EBIT Margin	-52.36%	45.70%	-9624.96%	-	-	-	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).